[Answered] According to a study conducted by Sharpe in 2012, _____ of transmen reported that they were afraid ...

This topic contains a solution. Click here to go to the answer

Author Question: According to a study conducted by Sharpe in 2012, _____ of transmen reported that they were afraid ... (Read 168 times)

dakota nelson

Hero Member
Posts: 604

on: Jun 18, 2018

According to a study conducted by Sharpe in 2012, _____ of transmen reported that they were afraid to tell their partner they were trans.

A) 9
B) 23
C) 38
D) 49

Question 2

Which of the following is the last stage of transition involved in reacting to one's romantic partner coming out?

A) Moving on
B) Numbness
C) Shock
D) Disbelief

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

tuate

Sr. Member
Posts: 332

Reply #1 on: Jun 18, 2018

Answer to Question 1

A

Answer to Question 2

A

dakota nelson

Member
Posts: 604

Reply 2 on: Jun 18, 2018

Great answer, keep it coming

okolip

Member
Posts: 362

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.